A new molecular marker of gastric cancer
Tuesday, March 31, 2009 - 06:42
in Health & Medicine
Gastric cancer (GC) is one of the most common malignancies in the world with a high incidence and death rate. TNM staging system is used worldwide to predict prognosis and direct therapeutic decisions of patients with GC. However, the prognoses of patients with stage 2 and 3 GC are more heterogeneous and less predictable by staging criteria. Therefore, finding molecular markers that are able to predict the potential of tumour recurrence and prognosis of patients is extremely important for appropriate individualised therapy...